Get started

Financials · ASPI

ASP Isotopes Inc. (ASPI) financials

For the twelve months ended Jun 30, 2026, ASP Isotopes Inc. reported $30.85M of revenue and -$117.34M of net income.

Revenue, TTM
$30.85M
Revenue growth, YoY
+573.4%
Net income, TTM
-$117.34M
Net margin
-380.3%
Free cash flow, TTM
-$83.58M
Cash
$219.60M
Total debt
$59.77M
P/S
10.61
Market cap
$327.3M
Annual revenue$23.85M
FY2022FY2025
Annual net income-$159.84M
FY2022FY2025
Annual free cash flow-$47.43M
FY2022FY2025

ASPI revenue and earnings growth

ASPI revenueQ2 2026$5.12M

Quarter YoY
+327.6%
QoQ
+22.6%
FY YoY
+475.5%

ASPI revenue was $5.12M in fiscal Q2 2026 (ended Jun 30, 2026), up 327.6% from a year earlier and up 22.6% from the prior quarter. For the full fiscal 2025 it was $23.85M, up 475.5% from fiscal 2024.

ASPI net incomeQ2 2026-$33.99M

ASPI net income was -$33.99M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$75.16M a year earlier. For the full fiscal 2025 it was -$159.84M, compared with -$32.42M in fiscal 2024.

ASPI EPSQ2 2026-$0.27

ASPI diluted EPS was -$0.27 in fiscal Q2 2026 (ended Jun 30, 2026). For the full fiscal 2025 it was -$2.11.

ASPI free cash flowQ2 2026-$27.42M

ASPI free cash flow was -$27.42M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$9.70M a year earlier. For the full fiscal 2025 it was -$47.43M, compared with -$26.37M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
Revenue$23.85M$4.14M$433.0K$0
Cost of revenue$20.44M$2.54M$294.1K$0
Gross profit$3.40M$1.60M$139.0K$0
Research and development$12.36M$3.14M$764.6K$1.27M
Selling, general and admin$48.24M$24.81M$15.42M$3.83M
Operating income-$59.91M-$26.35M-$16.04M-$5.10M
Interest expense$575.0K$259.0K$118.5K$0
Pre-tax income-$159.56M-$32.31M-$16.30M-$4.95M
Income tax$282.0K$111.0K-$6.1K$0
Net income-$159.84M-$32.42M-$16.29M-$4.95M
EPS, basic-$2.11-$0.63-$0.49-$0.18
EPS, diluted-$2.11-$0.63-$0.49-
Diluted shares83.0M55.7M33.1M-

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
Cash and equivalents$279.57M$61.89M$7.91M$2.39M
Short-term investments$47.74M$0--
Receivables--$216.5K$0
Inventory$1.10M$66.0K$0-
Current assets$399.92M$65.74M$10.51M$3.30M
Goodwill$5.18M$3.17M$3.27M$0
Total assets$498.02M$94.35M$27.54M$12.50M
Current liabilities$32.70M$7.06M$5.67M$1.94M
Short-term debt$584.0K$939.0K--
Long-term debt$1.47M$1.44M$0-
Total debt$2.06M$2.38M$0$10.0K
Total liabilities$235.12M$43.18M$8.71M$2.68M
Shareholders' equity$204.15M$51.17M$18.83M$9.82M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
Operating cash flow-$37.78M-$16.70M-$5.41M-$2.94M
Capital expenditures$9.65M$9.68M$2.33M$4.47M
Free cash flow-$47.43M-$26.37M-$7.74M-$7.41M
Investing cash flow-$110.79M-$11.37M-$2.45M-$4.47M
Financing cash flow$371.60M$82.53M$13.39M$6.64M
Dividends paid$0$2.78M$0-
Stock-based compensation$16.02M$8.56M$8.74M$2.00M
Depreciation and amortization$1.91M$471.0K--

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
Revenue growth, YoY475.5%857.0%--
Gross margin14.3%38.6%32.1%-
Operating margin-251.2%-636.0%-3704.6%-
Net margin-670.2%-782.4%-3762.9%-
Free cash flow margin-198.9%-636.4%-1788.3%-
Return on equity-78.3%-63.4%-86.5%-50.4%
Return on assets-32.1%-34.4%-59.2%-39.6%
Current ratio12.239.311.851.71
Debt to equity0.010.050.000.00

Source: XBRL data ASP Isotopes Inc. files with the SEC, latest filing dated Aug 14, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

ASPI peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
ASPI$30.85M+573.4%-$117.34M-380.3%$327.3M
LIN$36.24B+8.2%$7.01B19.3%$238.88B
APD$12.60B+4.5%-$47.30M-0.4%$69.27B
DOW$42.61B+4.2%-$897.00M-2.1%$22.41B
IFF$11.69B+24.3%$182.00M1.6%$21.14B
DD$7.06B+3.2%$301.00M4.3%$20.56B
LYB$31.96B+3.5%$1.30B4.1%$19.23B
ALB$6.15B+24.4%$681.63M11.1%$11.70B
SOLS$4.17B+9.4%$325.00M7.8%$10.01B

ASPI FAQ

8 questions
  • What is ASPI revenue?
    ASP Isotopes Inc. (ASPI) reported $30.85M of revenue for the twelve months ended Jun 30, 2026. That is up 573.4% from the year before. Revenue for fiscal 2025 was $23.85M.
  • Is ASPI profitable?
    No. ASP Isotopes Inc. reported a net loss of $117.34M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does ASPI have?
    ASP Isotopes Inc. reported $219.60M in cash and cash equivalents and $59.77M of debt on its most recent balance sheet in SEC filings.
  • How fast is ASPI revenue growing?
    ASP Isotopes Inc.'s revenue changed +475.5% in fiscal 2025, to $23.85M.
  • What is ASPI gross margin?
    ASP Isotopes Inc.'s gross profit was $5.65M on $30.85M of revenue for the twelve months ended Jun 30, 2026, a gross margin of 18.3%.
  • What is ASPI free cash flow?
    ASP Isotopes Inc. generated -$83.58M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of -$67.80M less capital expenditures.
  • When did ASPI last report financial results?
    The latest statements here come from ASP Isotopes Inc.'s 10-Q filed on Aug 14, 2026, covering the period ended Jun 30, 2026.
  • Where does this ASPI financial data come from?
    Quantisnow builds these statements from the structured XBRL data ASP Isotopes Inc. files with the SEC. It is provided for information only and is not investment advice.